Sunday, October 5, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Bullish on L3Harris Technologies with Upgraded Price Targets

Elaine Mendonca by Elaine Mendonca
January 11, 2024
in Breaking News
0
Technology Blockchain Trading online
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

JP Morgan analyst Seth Seifman has recently expressed his bullish outlook on L3Harris Technologies (NYSE:LHX), upgrading the stock from Neutral to Overweight. Seifman has set a price target of $240 for the company, indicating his confidence in its potential for growth.

This positive sentiment surrounding L3Harris Technologies is not limited to Seifman alone. Other analysts, including Wells Fargo and Deutsche Bank, have also raised their price targets for the stock. Wells Fargo now predicts a price target of $250, while Deutsche Bank aligns with Seifman’s target of $240.

The consensus among 25 analysts is that L3Harris Technologies has an average target price of $238. However, it is worth noting that there is a wide range of opinions among these analysts, with a high price target of $338 and a low price target of $164.

Seth Seifman, known for his expertise in the Industrial Goods sector, holds a reputable position at JP Morgan. With a success rate of 72.68%, he covers a total of 29 stocks, making his analysis highly regarded in the industry.

[bs_slider_forecast ticker=”LHX”]

L3Harris Technologies, Inc. (LHX) Shows Strong Performance and Positive Price Momentum on January 11, 2024

L3Harris Technologies, Inc. (LHX) has been showing strong performance in the stock market on January 11, 2024. According to data from CNN Money, LHX is currently trading near the top of its 52-week range and is also above its 200-day simple moving average. This suggests that the stock has been performing well and has been exhibiting positive price momentum.

The price of LHX shares experienced a slight decrease of $0.03 since the market last closed. This represents a drop of 0.01%. Despite this minor decline, LHX closed at a price of $203.47, indicating that the stock is still trading at a relatively high value.

However, it is worth noting that LHX has since seen a significant increase in pre-market trading. The stock has risen by $2.30, which suggests that there is strong buying interest in LHX shares before the market officially opens.

Overall, the performance of LHX on January 11, 2024, indicates that the stock is exhibiting positive price momentum. Trading near the top of its 52-week range and being above its 200-day simple moving average are positive indicators for investors. Additionally, the rise in pre-market trading further reinforces the positive sentiment surrounding LHX.

Investors and analysts will likely be closely monitoring LHX’s performance throughout the trading day to see if the positive momentum continues. It will be interesting to see if the stock can maintain its upward trajectory and potentially reach new highs.

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”LHX” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]

LHX Stock Performances on January 11, 2024: Financial Data Analysis and Potential for Recovery

LHX Stock Performances on January 11, 2024

On January 11, 2024, LHX’s stock performances were influenced by various factors, including the company’s financial data.

According to data from CNN Money, LHX’s total revenue for the past year was $17.06 billion, which is a decrease of 4.22% compared to the previous year. However, the company’s total revenue for the third quarter of the same year was $4.92 billion, showing an increase of 4.73% since the previous quarter.

The net income for LHX during the past year was $1.06 billion, marking a significant decrease of 42.47% compared to the previous year. However, the net income for the third quarter of the same year was $383.00 million, which indicates a positive increase of 9.74% since the previous quarter.

Earnings per share (EPS), a crucial metric for investors, were $5.49 for the past year. This represents a decline of 39.59% compared to the previous year. However, the EPS for the third quarter of the same year was $2.01, indicating a positive increase of 9.74% since the previous quarter.

The stock performances of LHX on January 11, 2024, were likely influenced by these financial figures. The decrease in total revenue and net income compared to the previous year may have raised concerns among investors. However, the positive increase in total revenue, net income, and EPS since the previous quarter may have provided some reassurance.

Investors may have been cautiously optimistic about the company’s ability to rebound from the decline in revenue and net income experienced in the past year. The positive growth in these figures since the previous quarter suggests that LHX may be on a path to recovery.

Overall, LHX’s stock performances on January 11, 2024, were likely influenced by the company’s financial data. The decrease in total revenue, net income, and EPS compared to the previous year may have initially raised concerns. However, the positive growth in these figures since the previous quarter may have provided some optimism for investors. As with any investment, it is important for investors to conduct thorough research and analysis before making any decisions.

Tags: LHX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Chick-fil-A_Apple_Pay

Wells Fargo Analyst Upgrades Willis Towers Watson Stock Sets Higher Price Target

Vevye The Revolutionary Solution for Dry Eye Disease

SK Life Science Inc Embraces Digital Transformation with Veeva Vault Validation Management

Recommended

MP Materials Stock

Rare Earth Miner Faces Competitive Challenge as Startup Secures Major Backing

7 days ago
RCI Hospitality Stock

CEO Purchase Signals Potential Turnaround for RCI Hospitality Stock

1 month ago
Juniper Networks Stock

Acquisition Approval Challenged as States Target HPE’s Juniper Purchase

4 weeks ago
Mobile app for healthcare

Innovative Device Quell Fibromyalgia Prescribed to Over 2000 Patients

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Marvell Technology Sends Mixed Signals to Investors

ProSiebenSat.1 Faces Critical Juncture as Digital Ambitions Clash with Traditional Weakness

Is Carrier Global Stock a Hidden Opportunity After Steep Decline?

UnitedHealth Scales Back Medicare Advantage Operations in Major Strategic Shift

Alibaba’s AI Transformation Fuels Spectacular Market Resurgence

Madrigal Stock: A Biotech Powerhouse’s Meteoric Rise

Trending

Ocugen Stock
Analysis

Biotech Firm Ocugen Sets Ambitious Three-Year Regulatory Timeline

by Felix Baarz
October 5, 2025
0

Ocugen has captured market attention with a bold regulatory roadmap, announcing plans to submit three gene therapy...

Robinhood Stock

Wall Street Heavyweights Bet Big on Robinhood’s Transformation

October 5, 2025
Fiserv Stock

Fiserv Stock: A Contrarian Bet Amid Market Pessimism

October 5, 2025
Marvell Technology Stock

Marvell Technology Sends Mixed Signals to Investors

October 5, 2025
ProSiebenSat1 Media Stock

ProSiebenSat.1 Faces Critical Juncture as Digital Ambitions Clash with Traditional Weakness

October 5, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Biotech Firm Ocugen Sets Ambitious Three-Year Regulatory Timeline
  • Wall Street Heavyweights Bet Big on Robinhood’s Transformation
  • Fiserv Stock: A Contrarian Bet Amid Market Pessimism

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com